
Ampio Pharmaceuticals AMPE
Geschäftsbericht 2023
hinzugefügt 27.03.2024
Ampio Pharmaceuticals EBITDA per Share 2011-2026 | AMPE
EBITDA per Share Jährlich Ampio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.15 | 1.39 | 0.08 | -0.0812 | -0.142 | -0.135 | -0.22 | -0.295 | -0.619 | -0.769 | -0.624 | -0.346 | -0.426 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.39 | -0.769 | -0.157 |
EBITDA per Share Vierteljährlich Ampio Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 0.46 | 0.02 | 0.02 | - | 0.06 | - | - | - | - | - | - | - | 0.01 | 0.01 | - | - | 0.01 | 0.01 | - | - | 0.01 | 0.01 | 0.01 | - | 0.02 | 0.01 | 0.01 | - | -0.14 | 0.01 | - | - | -0.18 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.46 | -0.18 | 0.0212 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-0.71 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Coherus BioSciences
CHRS
|
-1.54 | $ 1.57 | -3.68 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.82 | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 16.87 | -2.49 % | $ 789 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
12.6 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.67 | $ 7.47 | -4.6 % | $ 205 M | ||
|
Athira Pharma
ATHA
|
-23.7 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-3.51 | - | 0.74 % | $ 768 M | ||
|
Eton Pharmaceuticals
ETON
|
0.12 | $ 30.26 | 1.0 % | $ 814 M | ||
|
Galera Therapeutics
GRTX
|
-0.03 | - | -32.59 % | $ 7.61 M | ||
|
Exelixis
EXEL
|
3.32 | $ 50.13 | -1.9 % | $ 13.6 B | ||
|
Fortress Biotech
FBIO
|
-2.5 | $ 2.41 | 4.78 % | $ 67.2 M | ||
|
Midatech Pharma plc
MTP
|
-0.03 | - | -18.52 % | $ 27.3 M | ||
|
Forte Biosciences
FBRX
|
-5.45 | $ 23.11 | -3.55 % | $ 299 M | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 4.09 | -7.05 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.63 | 2.52 % | $ 434 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
BioNTech SE
BNTX
|
-5.81 | $ 89.55 | -2.65 % | $ 21.6 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
-2.84 | - | - | $ 231 M | ||
|
Galectin Therapeutics
GALT
|
-0.31 | $ 2.17 | -7.66 % | $ 139 M | ||
|
Gilead Sciences
GILD
|
8.35 | $ 129.58 | -1.88 % | $ 161 B | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.36 | -3.72 % | $ 5.53 M | ||
|
Aeterna Zentaris
AEZS
|
-3.37 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.05 | $ 0.72 | -1.58 % | $ 32.9 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Esperion Therapeutics
ESPR
|
0.29 | $ 3.12 | - | $ 649 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
Genmab A/S
GMAB
|
10.4 | $ 26.54 | -1.34 % | $ 1.72 B | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 21.32 | -1.16 % | $ 2.71 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | ||
|
Fennec Pharmaceuticals
FENC
|
-0.22 | $ 9.75 | 5.52 % | $ 279 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M |